mazindol has been researched along with Psychoses in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpenter, WT | 1 |
| Breier, A | 1 |
| Buchanan, RW | 1 |
| Kirkpatrick, B | 1 |
| Shepard, P | 1 |
| Weiner, E | 1 |
1 trial available for mazindol and Psychoses
| Article | Year |
|---|---|
Mazindol treatment of negative symptoms.
Topics: Adult; Analysis of Variance; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Fe | 2000 |